ZICC — Ziccum AB Share News
0.000.00%
- SEK12.77m
- SEK12.09m
- SEK3.75m
Brief: Ziccum Q2 Oper Loss Narrows To SEK 5.1 Mln
Brief: Ziccum Signs Evaluation Agreement For Feasibility Study
Brief: Ziccum Joint Proposal Not Selected For Detailed Application In CEPI Call
Brief: Ziccum Appoints Johny Humaloja As New CFO
Brief: Ziccum Q1 Loss Narrows To SEK 0.5 Mln
Brief: Ziccum Reports Positive Results From Drying Of Active mRNA
Brief: Ziccum Enters Into Partnership With Eucaps.com
Brief: Ziccum Q4 Result For Quarter At Loss Of SEK 8.0 Mln
Brief: Ziccum Q3 Oper Loss Widens To SEK 6.7 Mln
Brief: Ziccum Presents Results From Evaluation Study Analyzing LaminarPace
Brief: Ziccum Q2 Operating Loss Widens To SEK 7.9 Mln
Brief: Ziccum Installs New Cell Lab Enabling In-House In Vitro Research
Brief: Ziccum Q1 Operating Loss Widens To SEK 6.3 Mln
Brief: Ziccum Expands Lab Facilities And mRNA/LNP Capabilities
Brief: Ziccum Appoints Ann Gidner As New CEO
Brief: Ziccum Q4 Operating Loss Widens To SEK 6.5 Million
Brief: Ziccum Issues Shares And Warents Worth SEK 44 Mln
Brief: Ziccum Extends Evaluation Agreement With Global Pharmaceutical Company
Brief: Ziccum AB Interim Report Q3 2021